Xiaoping Xu

4.2k total citations
189 papers, 3.0k citations indexed

About

Xiaoping Xu is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaoping Xu has authored 189 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 42 papers in Molecular Biology and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaoping Xu's work include Radiopharmaceutical Chemistry and Applications (26 papers), Acute Myeloid Leukemia Research (16 papers) and Peptidase Inhibition and Analysis (14 papers). Xiaoping Xu is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (26 papers), Acute Myeloid Leukemia Research (16 papers) and Peptidase Inhibition and Analysis (14 papers). Xiaoping Xu collaborates with scholars based in China, United States and France. Xiaoping Xu's co-authors include Shaoli Song, Fei Huang, Weiliang Shu, Yan Chen, Zongbin Liu, Hongtao Feng, Yuanqing Zhang, Wenjiang Ding, Bobin Chen and Qudong Wang and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Xiaoping Xu

177 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Xu China 30 745 650 454 448 387 189 3.0k
Yanyu Zhang China 29 941 1.3× 409 0.6× 163 0.4× 367 0.8× 182 0.5× 137 3.4k
Weiguo Zhang China 32 1.1k 1.5× 344 0.5× 569 1.3× 561 1.3× 248 0.6× 114 3.7k
Long‐Sheng Lu Taiwan 24 1.0k 1.4× 858 1.3× 243 0.5× 279 0.6× 144 0.4× 66 2.9k
Han Jiang China 30 807 1.1× 327 0.5× 420 0.9× 756 1.7× 375 1.0× 165 3.0k
Chang Liu China 35 1.4k 1.8× 871 1.3× 217 0.5× 484 1.1× 170 0.4× 418 5.4k
Hong Zheng China 31 852 1.1× 776 1.2× 265 0.6× 394 0.9× 76 0.2× 153 3.2k
Dong Wook Kim South Korea 30 650 0.9× 957 1.5× 424 0.9× 519 1.2× 544 1.4× 250 3.6k
Mohammad F. Kiani United States 36 1.1k 1.5× 417 0.6× 461 1.0× 837 1.9× 569 1.5× 110 3.6k
Jiaping Li China 34 820 1.1× 674 1.0× 153 0.3× 832 1.9× 251 0.6× 199 4.4k
Wenli Zhang China 31 1.1k 1.5× 268 0.4× 111 0.2× 608 1.4× 245 0.6× 232 3.7k

Countries citing papers authored by Xiaoping Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Xu more than expected).

Fields of papers citing papers by Xiaoping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Xu. The network helps show where Xiaoping Xu may publish in the future.

Co-authorship network of co-authors of Xiaoping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Xu. A scholar is included among the top collaborators of Xiaoping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Xu. Xiaoping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Chunjuan, Miaoyan Wei, Panli Li, et al.. (2025). A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2362–2374.
2.
Liu, Cheng, et al.. (2024). Can 18F-FES PET Improve the Evaluation of 18F-FDG PET in Patients With Metastatic Invasive Lobular Carcinoma?. Clinical Nuclear Medicine. 49(4). 301–307. 7 indexed citations
3.
Liu, Fei, Panli Li, Junyan Xu, et al.. (2024). Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China. EJNMMI Research. 14(1). 119–119.
4.
5.
Xu, Xiaoping, et al.. (2022). Probabilistic Evaluation of Hydraulic Fracture Performance Using Ensemble Machine Learning. Geofluids. 2022. 1–9. 3 indexed citations
6.
7.
Liu, Zhaohui, Lei Zhang, Xiaoping Xu, et al.. (2020). Current Status of Immunotherapy for Metastatic Colorectal Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
8.
9.
Qiu, Yu, et al.. (2020). miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy. Neoplasma. 68(1). 87–95. 21 indexed citations
10.
11.
Hong, Yue, et al.. (2016). Analysis of fatty acids in olive oil and sea buckthorn oil by GC - MS. 31(5). 523. 1 indexed citations
12.
Xu, Xiaoping, Yao Zhu, Hengchuan Su, et al.. (2016). Preliminary clinical study of (99m)Tc-labelled small molecules against PSMA for prostate cancer imaging. Zhongguo aizheng zazhi. 26(7). 608–615. 1 indexed citations
13.
Zhuang, Lin, Yan Ma, Qian Wang, et al.. (2016). Atg3 Overexpression Enhances Bortezomib-Induced Cell Death in SKM-1 Cell. PLoS ONE. 11(7). e0158761–e0158761. 16 indexed citations
14.
Liu, Guangjun, Xiaoping Xu, & Feng Wang. (2014). Modeling of a Class of Nonlinear Dynamic System. SHILAP Revista de lepidopterología. 3 indexed citations
15.
Xu, Xiaoping. (2013). Evaluation of co-cultured CL-1 hepatocytes and hepatic stellate cells in rotatory cell culture system. 2 indexed citations
16.
17.
Zhang, Jing, Bobin Chen, Xiaoping Xu, et al.. (2012). Clinical Features of 66 Lymphoma Patients Presenting with a Fever of Unknown Origin. Internal Medicine. 51(18). 2529–2536. 10 indexed citations
18.
Xu, Xiaoping, et al.. (2011). Study on the anti-fatigue effect by taurine. 27(12). 1271–1273. 1 indexed citations
19.
Wang, Hong, Xiaoqin Wang, Xiaoping Xu, & Guowei Lin. (2009). Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome. Cancer Genetics and Cytogenetics. 196(2). 159–166. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanyu Zhang Breakdown of academic impact, for papers by Weiguo Zhang Breakdown of academic impact, for papers by Long‐Sheng Lu Breakdown of academic impact, for papers by Han Jiang Breakdown of academic impact, for papers by Chang Liu Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Dong Wook Kim Breakdown of academic impact, for papers by Mohammad F. Kiani Breakdown of academic impact, for papers by Jiaping Li Breakdown of academic impact, for papers by Wenli Zhang
Rankless by CCL
2026